These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27113481)

  • 1. Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.
    Nurminen R; Rantapero T; Wong SC; Fischer D; Lehtonen R; Tammela TL; Nykter M; Visakorpi T; Wahlfors T; Schleutker J
    Genes Chromosomes Cancer; 2016 Aug; 55(8):661-73. PubMed ID: 27113481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
    Nurminen R; Lehtonen R; Auvinen A; Tammela TL; Wahlfors T; Schleutker J
    Eur J Cancer; 2013 Oct; 49(15):3335-43. PubMed ID: 23830236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
    Dai JY; Wang X; Wang B; Sun W; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Feng Z; Stanford JL
    PLoS Genet; 2020 Mar; 16(3):e1008667. PubMed ID: 32226005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
    Laitinen VH; Rantapero T; Fischer D; Vuorinen EM; Tammela TL; ; Wahlfors T; Schleutker J
    Int J Cancer; 2015 May; 136(10):2316-27. PubMed ID: 25335771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.
    Fischer D; Wahlfors T; Mattila H; Oja H; Tammela TL; Schleutker J
    PLoS One; 2015; 10(5):e0127427. PubMed ID: 26020509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.
    Agalliu I; Wang Z; Wang T; Dunn A; Parikh H; Myers T; Burk RD; Amundadottir L
    PLoS One; 2013; 8(4):e60083. PubMed ID: 23573233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
    Sipeky C; Tammela TLJ; Auvinen A; Schleutker J
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1158-1166. PubMed ID: 34012061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition to prostate cancer.
    Benafif S; Eeles R
    Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.
    DeRycke MS; Larson MC; Nair AA; McDonnell SK; French AJ; Tillmans LS; Riska SM; Baheti S; Fogarty ZC; Larson NB; O'Brien DR; Cheville JC; Wang L; Schaid DJ; Thibodeau SN
    PLoS One; 2019; 14(4):e0214588. PubMed ID: 30958860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
    Amin Al Olama A; Kote-Jarai Z; Schumacher FR; Wiklund F; Berndt SI; Benlloch S; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Hunter DJ; Henderson BE; Thun MJ; Gaziano M; Giovannucci EL; Siddiq A; Travis RC; Cox DG; Canzian F; Riboli E; Key TJ; Andriole G; Albanes D; Hayes RB; Schleutker J; Auvinen A; Tammela TL; Weischer M; Stanford JL; Ostrander EA; Cybulski C; Lubinski J; Thibodeau SN; Schaid DJ; Sorensen KD; Batra J; Clements JA; Chambers S; Aitken J; Gardiner RA; Maier C; Vogel W; Dörk T; Brenner H; Habuchi T; Ingles S; John EM; Dickinson JL; Cannon-Albright L; Teixeira MR; Kaneva R; Zhang HW; Lu YJ; Park JY; Cooney KA; Muir KR; Leongamornlert DA; Saunders E; Tymrakiewicz M; Mahmud N; Guy M; Govindasami K; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English D; Virtamo J; Le Marchand L; Campa D; Kaaks R; Lindstrom S; Diver WR; Gapstur S; Yeager M; Cox A; Stern MC; Corral R; Aly M; Isaacs W; Adolfsson J; Xu J; Zheng SL; Wahlfors T; Taari K; Kujala P; Klarskov P; Nordestgaard BG; Røder MA; Frikke-Schmidt R; Bojesen SE; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Rinckleb A; Luedeke M; Herkommer K; Meyer A; Serth J; Marthick JR; Patterson B; Wokolorczyk D; Spurdle A; Lose F; McDonnell SK; Joshi AD; Shahabi A; Pinto P; Santos J; Ray A; Sellers TA; Lin HY; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao GW; Slavov C; Mitev V; ; ; ; ; Chanock S; Gronberg H; Haiman CA; Kraft P; Easton DF; Eeles RA
    Hum Mol Genet; 2013 Jan; 22(2):408-15. PubMed ID: 23065704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set.
    Thibodeau SN; French AJ; McDonnell SK; Cheville J; Middha S; Tillmans L; Riska S; Baheti S; Larson MC; Fogarty Z; Zhang Y; Larson N; Nair A; O'Brien D; Wang L; Schaid DJ
    Nat Commun; 2015 Nov; 6():8653. PubMed ID: 26611117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants at IRX4 as prostate cancer expression quantitative trait loci.
    Xu X; Hussain WM; Vijai J; Offit K; Rubin MA; Demichelis F; Klein RJ
    Eur J Hum Genet; 2014 Apr; 22(4):558-63. PubMed ID: 24022300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two independent prostate cancer risk-associated Loci at 11q13.
    Zheng SL; Stevens VL; Wiklund F; Isaacs SD; Sun J; Smith S; Pruett K; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Johansson JE; Liu W; Kim JW; Chang BL; Duggan D; Carpten J; Rodriguez C; Isaacs W; Grönberg H; Xu J
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1815-20. PubMed ID: 19505914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation screen and association studies in the diacylglycerol O-acyltransferase homolog 2 gene (DGAT2), a positional candidate gene for early onset obesity on chromosome 11q13.
    Friedel S; Reichwald K; Scherag A; Brumm H; Wermter AK; Fries HR; Koberwitz K; Wabitsch M; Meitinger T; Platzer M; Biebermann H; Hinney A; Hebebrand J
    BMC Genet; 2007 May; 8():17. PubMed ID: 17477860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer.
    Chung CC; Ciampa J; Yeager M; Jacobs KB; Berndt SI; Hayes RB; Gonzalez-Bosquet J; Kraft P; Wacholder S; Orr N; Yu K; Hutchinson A; Boland J; Chen Q; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman CA; Henderson BE; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Key TJ; Kaaks R; Isaacs WB; Isaacs SD; Grönberg H; Wiklund F; Xu J; Vatten LJ; Hveem K; Njolstad I; Gerhard DS; Tucker M; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chatterjee N; Chanock SJ
    Hum Mol Genet; 2011 Jul; 20(14):2869-78. PubMed ID: 21531787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Candidate mRNA Isoforms for Prostate Cancer-Risk SNPs Utilizing Iso-eQTL and sQTL Methods.
    Moradi A; Sharma H; Sharma RD; Fernando A; Barrero RA; Batra J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer.
    Camp NJ; Swensen J; Horne BD; Farnham JM; Thomas A; Cannon-Albright LA; Tavtigian SV
    Genet Epidemiol; 2005 Apr; 28(3):232-43. PubMed ID: 15593091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
    Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
    Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post genome-wide association studies functional characterization of prostate cancer risk loci.
    Jiang J; Cui W; Vongsangnak W; Hu G; Shen B
    BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S9. PubMed ID: 24564736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.